The authorization of an additional $300 million for stock repurchase is likely to positively impact Chemed's stock price as it indicates confidence in the company's financial health and can reduce the number of shares outstanding, potentially increasing EPS. The declaration of a 50-cent dividend further signals financial stability and commitment to returning value to shareholders.